Antibodies against Haemophilus influenzae type b capsular polysaccharide and tetanus toxoid before and after a booster dose of the carrier protein nine years after primary vaccination with a protein conjugate vaccine

Pediatric Infectious Disease Journal

Volumn 24, Issue 5, 2005, Pages 463-464

  Claesson, Bo A ^a   Trollfors, Birger ^a   Lagergård, Teresa ^a   Knutsson, Nina ^a   Schneerson, Rachel ^b   Robbins, John B ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Conjugate vaccine; Haemophilus influenzae; Tetanus toxoid

Indexed keywords

BACTERIAL POLYSACCHARIDE; CARRIER PROTEIN; DIPHTHERIA TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN G ANTIBODY; TETANUS TOXOID;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCHOOL CHILD; VACCINATION;

ANTIBODIES, BACTERIAL; CARRIER PROTEINS; CHILD; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HAEMOPHILUS INFECTIONS; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; MALE; SENSITIVITY AND SPECIFICITY; TETANUS TOXOID; TIME FACTORS; VACCINATION; VACCINES, CONJUGATE;

EID: 18644372123     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000160955.26151.71     Document Type: Article

References (8)

1. Claesson BA, Trollfors B, Anderson PW, et al. Serum antibodies in 6-year-old children vaccinated in infancy with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. Pediatr Infect Dis J. 1996; 15: 170-172.
2. Mäkelä PH, Käyhty H, Leino T, et al. Long-term persistence of immunity after immunisation with Haemophilus influenzae type b conjugate vaccine. Vaccine. 2003;22:287-292.
3. Schneerson R, Robbins JB, Chu C, et al. Serum antibody responses of juvenile and infant rhesus monkeys with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates. Infect Immun. 1984;45:582-591.
4. Granoff DM, Holmes SJ, Belshe RB, et al. Effect of carrier protein priming on antibody response to Haemophilus influenzae type b conjugate vaccines in infants. JAMA. 1994;272:1116-1121.
5. Kurikka S. Priming with diphtheria-tetanus-pertussis vaccine enhances the response to the Haemophilus influenza type b tetanus conjugate vaccine in infancy. Vaccine. 1996;14:1239-1242.
6. Claesson BA, Schneerson R, Lagergård T, et al. Persistence of serum antibodies elicited by Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants vaccinated at 3, 5 and 12 months of age. Pediatr Infect Dis J. 1991;10:560-564.
7. Sutton A, Vann WF, Karpas AB, Steim KE, Schneerson R. An avidinbiotin-based ELISA for quantitation of antibody to bacterial polysaccharides. J Immunol Methods. 1985;82:215-224.
8. Taranger J, Trollfors B, Lagergård T. Clinical Trials of a Monocomponent Pertussis Toxoid Vaccine: A Technical Report. Göteborg, Sweden: Graphic Systems; 1995.